SCHEMBL1089281

SCHEMBL1089281

c1ccc(COc2ccc(CN3CCCC(Nc4nccc(N5CCCCCC5)n4)C3)cc2OCc2ccccc2)cc1

nearest known ligand 0.69

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CXCR4 P61073 1/20 0.69
EHMT2 Q96KQ7 4/20 0.49
MEN1 O00255 1/20 0.48
KMT2A Q03164 1/20 0.48
KDM4E B2RXH2 1/20 0.46
ALDH1A1 P00352 1/20 0.46
LMNA P02545 1/20 0.46
TSHR P16473 1/20 0.46
MAPK1 P28482 1/20 0.46
HTT P42858 1/20 0.46
ACHE P22303 2/20 0.44
HRH4 Q9H3N8 1/20 0.42
HRH3 Q9Y5N1 1/20 0.41
ROCK2 O75116 2/20 0.41
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41
CCR2 P41597 1/20 0.41
ROCK1 Q13464 1/20 0.41
BACE1 P56817 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1090648 0.96 CXCR4 (0.76) CXCR4EHMT2MEN1KMT2AKDM4E
SCHEMBL1091041 0.95 CXCR4 (0.65) CXCR4EHMT2MEN1KMT2AKDM4E
SCHEMBL1089797 0.93 CXCR4 (0.66) CXCR4EHMT2MEN1KMT2AKDM4E
SCHEMBL1090277 0.91 CXCR4 (0.71) CXCR4EHMT2MEN1KMT2AKDM4E
SCHEMBL1088506 0.91 CXCR4 (0.67) CXCR4EHMT2MEN1KMT2AKDM4E
SCHEMBL1089428 0.89 CXCR4 (0.70) CXCR4EHMT2KDM4EALDH1A1LMNA
SCHEMBL1089520 0.89 CXCR4 (0.76) CXCR4EHMT2HTTACHEHRH4
SCHEMBL1091199 0.88 CXCR4 (0.61) CXCR4EHMT2MEN1KMT2AKDM4E
SCHEMBL1089515 0.88 CXCR4 (0.69) CXCR4EHMT2ACHEHRH4HRH3
SCHEMBL1088952 0.87 CXCR4 (0.90) CXCR4EHMT2ACHEHRH4HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120156219-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2012-06-21 US disclosed
US-8153625-B2 Nitrogen-containing heterocyclic compounds and medicinal use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2012-04-10 US disclosed
US-20100221259-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2010-09-02 US disclosed
US-7759336-B2 Nitrogen-containing heterocyclic compounds and medicinal use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2010-07-20 US disclosed
US-20070167459-A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2007-07-19 US disclosed
EP-1571146-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2005-09-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100221259-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF CXCR4, CXCL12, CXCR3 CXCR4 1/4885EHMT2 2402/4885MEN1 3648/4885
US-20070167459-A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof CXCR4, CXCL12, CXCR3 CXCR4 1/4885EHMT2 2402/4885MEN1 3648/4885
US-20120156219-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF CXCR4, CXCL12, CXCR3 CXCR4 1/4885EHMT2 2402/4885MEN1 3648/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.